Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M214Revenue $M79.7Net Margin (%)-35.1Z-Score11.3
Enterprise Value $M126EPS $-1.4Operating Margin %-35.9F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-35.2Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %0Quick Ratio10.9Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %0Current Ratio12.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-18.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-20.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M25.2ROI % (ttm)-27.1Gross Margin Increase y-yY

Gurus Latest Trades with DSCI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

DSCI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

DSCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wolfenson BarrySee Remarks 2014-09-16Buy3,750$7.992.75 view
Wolfenson BarrySee Remarks 2014-05-19Buy11,250$8.79-6.6 view
QUILTY EDWARD JPresident & CEO 2014-05-16Buy10,000$8.7-5.63 view
RA CAPITAL MANAGEMENT, LLC 2014-01-10Sell300,000$11.83-30.6 view
STAFFORD C RICHARDDirector 2013-09-03Sell15,000$14.06-41.61 view
YETTER JOHN EEVP, Finance & CFO 2013-09-03Sell12,100$14.16-42.02 view
YETTER JOHN EExecutive VP, Finance & CFO 2013-08-28Sell400$14.03-41.48 view
MARTIN WILLIAM C10% Owner 2013-05-30Sell95,568$13.68-39.99 view
RA CAPITAL MANAGEMENT, LLC10% Owner 2013-04-29Buy3,945$11.4-27.98 view
MARTIN WILLIAM C10% Owner 2013-04-02Sell97,324$12.33-33.41 view

Press Releases about DSCI :

    Quarterly/Annual Reports about DSCI:

    News about DSCI:

    Articles On GuruFocus.com
    Derma Sciences Inc. Reports Operating Results (10-Q) Nov 12 2010 
    Derma Sciences Inc. Reports Operating Results (10-Q) May 12 2010 

    More From Other Websites
    DERMA SCIENCES, INC. Financials Aug 20 2014
    Derma Sciences to Present at Canaccord Genuity 34th Annual Growth Conference on August 14 Aug 12 2014
    Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today Aug 07 2014
    Derma Sciences Reports Second Quarter Financial Results Aug 07 2014
    Q2 2014 Derma Sciences, Inc. Earnings Release - Before Market Open Aug 07 2014
    DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report Aug 06 2014
    Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 7th Aug 01 2014
    Derma Sciences CEO Discusses Continued Growth of MEDIHONEY® at Comvita Annual Meeting of... Jul 25 2014
    Derma Sciences announces Veterans Administration adds AMNIOEXCEL® to its Federal Supply Schedule Jul 22 2014
    Derma (DSCI) is in Overbought Territory: What's Next? Jun 19 2014
    Derma Sciences, Inc. to Webcast June 17th Analyst Day Jun 13 2014
    [video] Derma Sciences CEO: Medihoney Sales Sweet and Getting Sweeter May 29 2014
    DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... May 23 2014
    Derma Sciences management to meet with Oppenheimer May 22 2014
    Derma Sciences' (DSCI) CEO Ed Quilty on Q1 2014 Results - Earnings Call Transcript May 09 2014
    Derma Sciences affirms FY14 net sales view $92M, consensus $91.78M May 08 2014
    Derma Sciences reports Q1 EPS (46c), consensus (32c) May 08 2014
    Derma Sciences Reports First Quarter Financial Results May 08 2014
    DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report May 07 2014
    Derma Sciences to Present at Sidoti Semiannual Micro-Cap Conference on May 9 May 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial